Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease

The field related to mood disorders in Parkinson’s disease (PD) is fragmented. The aim of this cohort observational study was to evaluate whether the episodes of mood alteration could appear in different disease stages and to verify how nonmotor symptoms were led off into different stages. We enroll...

Full description

Saved in:
Bibliographic Details
Main Authors: Margherita Canesi, Sara Lavolpe, Viviana Cereda, Alessandra Ranghetti, Roberto Maestri, Gianni Pezzoli, Maria Luisa Rusconi
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.1155/2020/5139237
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568557279379456
author Margherita Canesi
Sara Lavolpe
Viviana Cereda
Alessandra Ranghetti
Roberto Maestri
Gianni Pezzoli
Maria Luisa Rusconi
author_facet Margherita Canesi
Sara Lavolpe
Viviana Cereda
Alessandra Ranghetti
Roberto Maestri
Gianni Pezzoli
Maria Luisa Rusconi
author_sort Margherita Canesi
collection DOAJ
description The field related to mood disorders in Parkinson’s disease (PD) is fragmented. The aim of this cohort observational study was to evaluate whether the episodes of mood alteration could appear in different disease stages and to verify how nonmotor symptoms were led off into different stages. We enrolled 93 PD outpatients (three groups: drug naive—DN; not exhibiting motor fluctuations—n-MF; and exhibiting motor fluctuations—MF) and 50 healthy controls. Mood state was assessed through the Internal State Scale (ISS) while depressive symptoms were evaluated through the Beck Depression Inventory-II (BDI-II), nonmotor symptoms by means of the Non-Motor Symptoms Scale (NMSS), and the presence of impulse control disorders (ICDs) with the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease (QUIP). Clinical and pharmacological data have also been recorded. No significant differences in mood state distribution between groups were observed. Nevertheless, as regards the mood state distribution within groups, in n-MF (47.6%) and MF patients (50%), (hypo)mania presence was significantly higher than other symptoms. In DN patients, hypomania showed a prevalence of 38.1% although it was not significant. At least one ICD was reported in 29.3% of n-MF and 50% of MF patients. In the MF group, a moderate positive correlation between ISS ACTivation subscale scores and the presence of ICDs and compulsive medication use emerged. Finally, MF patients reported higher BDI-II total scores than DN. Our results show that mood alterations in PD, considering both depressive symptoms and mood elevation, are related to the advanced stages of the disease as well as the presence of ICDs, and dopaminergic therapy would not always be able to restore a normal mood condition.
format Article
id doaj-art-32127ab6585c4edd95b4be1d59e8f0e2
institution Kabale University
issn 0953-4180
1875-8584
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Behavioural Neurology
spelling doaj-art-32127ab6585c4edd95b4be1d59e8f0e22025-02-03T00:58:47ZengWileyBehavioural Neurology0953-41801875-85842020-01-01202010.1155/2020/51392375139237Hypomania, Depression, Euthymia: New Evidence in Parkinson’s DiseaseMargherita Canesi0Sara Lavolpe1Viviana Cereda2Alessandra Ranghetti3Roberto Maestri4Gianni Pezzoli5Maria Luisa Rusconi6Department of Parkinson’s Disease, Movement Disorders & Brain Injury Rehabilitation, ‘Moriggia-Pelascini’ Hospital-Gravedona ed Uniti, Como, ItalyDepartment of Human and Social Sciences, University of Bergamo, ItalyDepartment of Parkinson’s Disease, Movement Disorders & Brain Injury Rehabilitation, ‘Moriggia-Pelascini’ Hospital-Gravedona ed Uniti, Como, ItalyDepartment of Parkinson’s Disease, Movement Disorders & Brain Injury Rehabilitation, ‘Moriggia-Pelascini’ Hospital-Gravedona ed Uniti, Como, ItalyDepartment of Biomedical Engineering, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, ItalyParkinson Institute, ASST G.Pini-CTO, Milan, ItalyDepartment of Human and Social Sciences, University of Bergamo, ItalyThe field related to mood disorders in Parkinson’s disease (PD) is fragmented. The aim of this cohort observational study was to evaluate whether the episodes of mood alteration could appear in different disease stages and to verify how nonmotor symptoms were led off into different stages. We enrolled 93 PD outpatients (three groups: drug naive—DN; not exhibiting motor fluctuations—n-MF; and exhibiting motor fluctuations—MF) and 50 healthy controls. Mood state was assessed through the Internal State Scale (ISS) while depressive symptoms were evaluated through the Beck Depression Inventory-II (BDI-II), nonmotor symptoms by means of the Non-Motor Symptoms Scale (NMSS), and the presence of impulse control disorders (ICDs) with the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease (QUIP). Clinical and pharmacological data have also been recorded. No significant differences in mood state distribution between groups were observed. Nevertheless, as regards the mood state distribution within groups, in n-MF (47.6%) and MF patients (50%), (hypo)mania presence was significantly higher than other symptoms. In DN patients, hypomania showed a prevalence of 38.1% although it was not significant. At least one ICD was reported in 29.3% of n-MF and 50% of MF patients. In the MF group, a moderate positive correlation between ISS ACTivation subscale scores and the presence of ICDs and compulsive medication use emerged. Finally, MF patients reported higher BDI-II total scores than DN. Our results show that mood alterations in PD, considering both depressive symptoms and mood elevation, are related to the advanced stages of the disease as well as the presence of ICDs, and dopaminergic therapy would not always be able to restore a normal mood condition.http://dx.doi.org/10.1155/2020/5139237
spellingShingle Margherita Canesi
Sara Lavolpe
Viviana Cereda
Alessandra Ranghetti
Roberto Maestri
Gianni Pezzoli
Maria Luisa Rusconi
Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
Behavioural Neurology
title Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
title_full Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
title_fullStr Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
title_full_unstemmed Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
title_short Hypomania, Depression, Euthymia: New Evidence in Parkinson’s Disease
title_sort hypomania depression euthymia new evidence in parkinson s disease
url http://dx.doi.org/10.1155/2020/5139237
work_keys_str_mv AT margheritacanesi hypomaniadepressioneuthymianewevidenceinparkinsonsdisease
AT saralavolpe hypomaniadepressioneuthymianewevidenceinparkinsonsdisease
AT vivianacereda hypomaniadepressioneuthymianewevidenceinparkinsonsdisease
AT alessandraranghetti hypomaniadepressioneuthymianewevidenceinparkinsonsdisease
AT robertomaestri hypomaniadepressioneuthymianewevidenceinparkinsonsdisease
AT giannipezzoli hypomaniadepressioneuthymianewevidenceinparkinsonsdisease
AT marialuisarusconi hypomaniadepressioneuthymianewevidenceinparkinsonsdisease